INTEGRATE II opens to recruitment

INTEGRATE II, an AGITG led Phase III clinical trial in gastro-oesophageal cancer has opened to recruitment with the first site at The Townsville Hospital in Douglas, Queensland.  Support for the final INTEGRATE II trial design was received from Bayer in November 2015.  INTEGRATE II is a Randomised Phase III Double-Blind … Read More

October 20, 2016

AGITG ASM – Looking Back Moving Forward

This year marked the 25th anniversary of the Australasian Gastro-Intestinal Trials Group (AGITG) conducting and promoting clinical trials and related biological research in gastro-intestinal (GI) cancer. Looking back over 25 years and moving forward, the meeting presented information on the latest cutting edge research and evidence based treatments from leading … Read More

October 10, 2016

NABNEC is now open to recruitment

NABNEC, a randomised Phase II clinical trial recently funded by the NHMRC and supported by Specialised Therapeutics Australia (STA), is now open to patient recruitment. Currently sites open for this trial include: Royal North Shore Hospital, Westmead Hospital and Calvary Mater Newcastle Hospital. Sites still to be activated are located … Read More

October 7, 2016

QUASAR 2 Study published in Lancet Oncology

The QUASAR 2 clinical trial, a multicentre international study of capecitabine +/- bevacizumab as adjuvant treatment of colorectal cancer, was recently published in The Lancet Oncology. Chemotherapy given after surgery to patients with early-stage bowel cancer improves the disease cure rate. However, despite this the cancer often returns. 5 Fluorouracil … Read More

October 6, 2016

AGITG Trial News

The AGITG currently has seven studies open to recruitment and ten studies in follow up. The table below details the trials that are currently accruing patients. Recruited Target ACTICCA-1- Gallbladder carcinoma 0 50 ALT-GIST- GI Stromal Tumour 24 240 ASCOLT – Colorectal cancer 170 200 CONTROL NETs – NeuroEndocrine Tumour 31 48 INTERAACT – Anal cancer … Read More

October 5, 2016

AGITG Best Site Award

Ms Halina Steane is pictured with AGITG Chair, Professor Tim Price. The AGITG Best Site Award, introduced in 2015, was awarded to The Royal Hobart Hospital Centre for Clinical Research Haematology and Oncology Clinical Trials team (RHH CCR). RHH CCR has been involved with the AGITG since the early 1990’s when … Read More

September 30, 2016

Best New Concept, Poster and Fast Forward

Best of New Concepts Award The New Concepts Symposium is sponsored by independent biopharmaceutical company Specialised Therapeutics Australia, in a key demonstration of its commitment to cancer research and the development of new therapeutics that may change lives. In 2016, the New Concepts Symposium featured four excellent presentations of embryonic research concepts. … Read More

September 30, 2016

AGITG Innovation Fund awarded for colorectal cancer research

Dr Matthew Burge (right) is pictured with Professor Tim Price. Dr Matthew Burge from the Royal Brisbane and Women’s Hospital has been awarded the 2016 AGITG Innovation Fund. The AGITG Innovation Fund is made possible by the generosity of charitable donations raised through the GI Cancer Institute Gutsy Challenge. Dr … Read More

September 30, 2016

John Zalcberg OAM Award for Excellence

Professor Goldstein (middle) is pictured with his wife Jenny and Professor John Zalcberg OAM (left).   The ‘John Zalcberg OAM Award for Excellence in AGITG Clinical Trials Research’ this year was awarded to Conjoint Professor David Goldstein of Prince of Wales Hospital (Sydney) in recognition of his significant and outstanding … Read More

September 30, 2016

Pancreas Cancer Research Workshop 2016

The AGITG and the Australasian Pancreas Club hosted the 4th Annual Pancreas Cancer Research Workshop on Tuesday 13 September, immediately preceding the AGITG 18th Annual Scientific Meeting. The meeting was a resounding success with very good attendance across disciplines and robust, research-centred discussion. We had two outstanding invited speakers, the first … Read More

September 19, 2016